Blood Banks Market
By Product Type;
Whole Blood, Red Blood Cell, Platelet, Plasma, and White Blood cellBy Function;
Collection, Processing, Testing, Storage, and TransportationBy Bank Type;
Private and PublicBy End User;
Hospital, Ambulatory Surgery Centers, Pharmaceutical Companies, Clinics & Nursing Homes, and OthersBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)Blood Bank Market Overview
Blood Bank Market (USD Million)
Blood Bank Market was valued at USD 19,814.93 million in the year 2024. The size of this market is expected to increase to USD 27,881.59 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 5.0%.
Blood Banks Market
*Market size in USD million
CAGR 5.0 %
Study Period | 2025 - 2031 |
---|---|
Base Year | 2024 |
CAGR (%) | 5.0 % |
Market Size (2024) | USD 19,814.93 Million |
Market Size (2031) | USD 27,881.59 Million |
Market Concentration | Medium |
Report Pages | 323 |
Major Players
- American Association of Blood Banks
- Illinois Medical District
- Scottish National Blood
- America's Blood Centers
- Australian Red Cross Society
- Blood Bank of Alaska
- Canadian Blood Services
- Japanese Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- The American Red Cross
- Viitant
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Blood Banks Market
Fragmented - Highly competitive market without dominant players
The Blood Bank Market is expanding as the demand for blood components increases in areas such as surgeries, cancer therapies, and chronic illness management. Around 60% of the blood supply is consumed for these medical interventions, prompting advancements in processing and storage solutions within blood banks.
Adoption of Advanced Technologies
Blood banks are improving operational workflows through the use of automated diagnostic tools, AI-enabled inventory systems, and intelligent cooling devices. Nearly 47% of facilities have implemented such solutions, resulting in enhanced tracking accuracy and reduced spoilage rates.
Growth in Voluntary Donor Base
With increasing public awareness, voluntary donations now contribute approximately 70% of total blood collections. Enhanced outreach via digital platforms and mobile collection services is making donation more accessible, ensuring a steady supply for both emergency and planned medical needs.
Widening Application in Therapies
Blood products are increasingly used beyond conventional transfusions, with nearly 33% of collected plasma applied in therapeutic procedures like plasma exchange, stem cell regeneration, and autoimmune treatment. This shift is creating new growth avenues within the market.
Blood Bank Market Recent Developments
-
In April 2022, The Scottish National Blood Transfusion Services launched an advertising campaign, " people like you," featuring blood donors from across Scotland. This campaign had the objective to recruit new blood donors and serve the hospitals with the blood demand in the hospitals.
-
In September 2021, The Illinois Medical District (IMD) in Chicago partnered with the American Red Cross to encourage people from racial and ethnic minorities to donate blood.
Segment Analysis
In this report, the Blood Bank Market has been segmented by Product Type, Function, Bank Type, End User, and Geography.
Blood Bank Market, Segmentation by Product Type
The Blood Bank Market has been segmented by Product Type into Whole Blood, Red Blood Cell, Platelet, Plasma and White Blood cell.
Whole Blood
Whole Blood represents about 30% of the global blood bank market. It is widely used in trauma care and surgeries due to its ability to provide a complete blood profile, including red cells, white cells, plasma, and platelets. Its versatility makes it indispensable in emergency medical interventions.
Red Blood Cell
Red Blood Cells (RBCs) lead the market with a share of approximately 35%. These are frequently used for patients with anemia, significant blood loss, and chronic oxygen deficiency. Their stability and targeted function make RBCs a key product in transfusion medicine.
Platelet
Platelets contribute nearly 15% to the blood bank market. They are critical for patients undergoing chemotherapy, organ transplants, and complex surgeries. Owing to their limited shelf life, platelet availability remains a logistical challenge yet a vital necessity.
Plasma
Plasma accounts for nearly 17% of the market and is essential for patients with coagulation disorders, burns, and liver diseases. The demand for plasma is increasing with the rise in plasma-based therapies, thanks to its rich protein and clotting factor composition.
White Blood Cell
White Blood Cells (WBCs) comprise about 3% of the market. Though less commonly transfused, they are vital for specific immune-compromised cases such as bone marrow transplant recipients. Despite their niche application, they serve an irreplaceable role in critical care.
Blood Bank Market, Segmentation by Function
The Blood Bank Market has been segmented by Function into Collection, Processing, Testing, Storage, and Transportation.
Collection
Collection represents the largest share of around 32% in the functional segmentation of the blood bank market. It involves the systematic gathering of blood donations through donation drives and centers while maintaining hygiene and regulatory standards. Efficient collection is vital for ensuring a consistent and safe blood supply.
Processing
Processing, which contributes about 24% of the market, focuses on separating whole blood into its individual components like red blood cells, platelets, and plasma. This step ensures optimal utilization and supports targeted treatment for various medical conditions.
Testing
Testing holds approximately 18% of the market. It plays a critical role in verifying the safety and quality of collected blood through rigorous screening for infectious diseases. This function ensures only safe and compatible blood is used in medical procedures.
Storage
Storage accounts for nearly 16% of the market share. Blood components must be stored under controlled conditions to maintain their viability. Proper storage infrastructure is crucial to reduce wastage and ensure emergency readiness.
Transportation
Transportation, with a 10% share, ensures the safe and timely delivery of blood and its components to healthcare facilities. The use of insulated containers and temperature monitoring systems is vital to maintain the efficacy of blood during transit.
Blood Bank Market, Segmentation by Bank Type
The Blood Bank Market has been segmented by Bank Type into Private and Public.
Private
Private blood banks hold the majority share of the market, accounting for approximately 58%. These institutions are managed by for-profit entities and are known for offering advanced infrastructure, quick service delivery, and personalized care. They are commonly chosen by patients and healthcare providers for emergency and elective procedures requiring specific blood components.
Public
Public blood banks represent about 42% of the market. Typically run by government agencies or non-profit organizations, they are essential for ensuring an equitable and reliable blood supply across public hospitals. These banks focus on large-scale donations and distribution as part of national healthcare programs.
Blood Bank Market, Segmentation by End User
The Blood Bank Market has been segmented by End User into Hospital, Ambulatory Surgery Centers, Pharmaceutical Companies, Clinics & Nursing Homes, and Others.
Hospital
Hospitals are the primary end users in the blood bank market due to their high demand for blood transfusions during surgeries, trauma care, and treatments of chronic diseases. They account for nearly 35% of the total end-user share. Their dependence on a steady blood supply makes them critical players in this ecosystem.
Ambulatory Surgery Centers
Ambulatory Surgery Centers (ASCs) utilize blood components for minor to moderate procedures and are gaining traction with the rise in outpatient surgeries. They contribute around 15% to the market share and emphasize efficiency and quick turnaround times in blood usage.
Pharmaceutical Companies
Pharmaceutical companies are key end users, especially in biologic drug development and plasma-derived therapies. With around 12% market share, they rely on blood-derived materials for research and manufacturing, making them a growing segment.
Clinics & Nursing Homes
Clinics and nursing homes often require limited quantities of blood for routine treatments and elderly care. Though smaller in volume, they collectively represent 10% of the market. Their reliance is mainly on pre-screened blood products.
Others
This segment includes diagnostic labs, research institutions, and emergency services. Combined, they account for roughly 28% of the market and play a critical role in specialized blood testing and public health preparedness.
Blood Bank Market, Segmentation by Geography
In this report, the Blood Bank Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Regions and Countries Analyzed in this Report
Blood Bank Market Share (%), by Geographical Region
North America
North America holds the largest share in the global blood bank market, contributing nearly 38% due to its advanced healthcare infrastructure, strong regulatory framework, and high awareness levels. The region benefits from a well-established blood donation network and rapid adoption of automation technologies.
Europe
Europe commands around 25% of the market, supported by government-funded healthcare systems and stringent blood safety regulations. The demand is driven by a growing aging population, increasing chronic conditions, and consistent efforts in blood storage and quality control.
Asia Pacific
Asia Pacific is the fastest-growing region, expected to witness a CAGR of over 7% in the coming years. The growth is fueled by rising healthcare expenditure, increased blood donation awareness, and supportive government initiatives, especially in countries like India and China.
Middle East and Africa
The Middle East and Africa collectively account for 6%–8% of the market. Growth in this region is primarily due to infrastructure development, increasing prevalence of communicable diseases, and growing public-private partnerships in healthcare services.
Latin America
Latin America holds a modest market share of around 5%, driven by gradual improvements in healthcare accessibility and blood screening processes. Countries like Brazil and Mexico are contributing through national blood programs and public health campaigns.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Blood Bank Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Demand growth
- Technological advancements
- Regulatory compliance
-
Emerging markets - Emerging markets in the context of the global blood bank industry represent regions with developing healthcare infrastructure, increasing healthcare expenditures, and growing awareness about the importance of blood donation. These markets present significant opportunities for the expansion and enhancement of blood banking services.
Emerging markets such as those in parts of Asia, Latin America, and Africa are experiencing rapid growth in healthcare infrastructure. Governments and private sectors are investing in hospitals, clinics, and blood transfusion centers to improve access to healthcare services, including blood transfusions. This development is crucial for expanding the reach of blood banks to more remote and underserved communities.
As economies in emerging markets grow, there is an increase in healthcare spending by both governments and individuals. This trend supports the development of sophisticated blood banking technologies and facilities. Blood banks in these regions are investing in advanced equipment for blood processing, testing, and storage, which enhances the quality and safety of blood products available for transfusion.
Restraints
- Supply shortages
- Donor recruitment challenges
- Regulatory complexities
-
High operational costs - High operational costs in the blood bank industry pose significant challenges and impact various aspects of service delivery and sustainability:
Blood banks require specialized equipment for blood collection, processing, testing, storage, and transportation. These technologies are often expensive to acquire, maintain, and upgrade. Advanced equipment is necessary to ensure the safety and quality of blood products, but it comes with high initial costs and ongoing operational expenses.
Blood banking operations rely on skilled professionals such as phlebotomists, laboratory technicians, and quality assurance experts. Recruiting and retaining qualified staff and providing continuous training to keep up with evolving technologies and regulatory requirements add to operational costs.
Blood banks must adhere to stringent regulatory standards and quality control measures to ensure the safety of blood products. Compliance with regulations requires investments in infrastructure, personnel, and ongoing monitoring and audits, which contribute to high operational costs.
Opportunities
- Blood product innovations
- Expansion in emerging markets
- Advancements in storage and transportation
-
Collaborations with pharmaceutical companies - Collaborations between blood banks and pharmaceutical companies offer several strategic opportunities and benefits:
Pharmaceutical companies often collaborate with blood banks to advance research and development efforts. This partnership allows for the exploration of new therapies, medications, and diagnostic tools that rely on blood components. For example, pharmaceutical companies may use blood products in clinical trials to assess drug efficacy or safety.
Collaborations can enhance the efficiency of the blood supply chain. Pharmaceutical companies may contribute expertise in logistics, distribution networks, and quality management systems, helping blood banks improve their operational processes and ensure timely delivery of blood products to healthcare facilities.
Pharmaceutical companies may require specific blood products or components for their research and development activities. Blood banks can tailor their collection and processing strategies to meet these specialized needs, thereby diversifying their product offerings and potentially increasing revenue streams.
Competitive Landscape Analysis
Key players in Global Blood Bank Market include;
- American Association of Blood Banks
- Illinois Medical District
- Scottish National Blood
- America's Blood Centers
- Australian Red Cross Society
- Blood Bank of Alaska
- Canadian Blood Services
- Japanese Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- The American Red Cross
- Viitant
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Function
- Market Snapshot, By Bank Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Blood Bank Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Demand growth
- Technological advancements
- Regulatory compliance
- Emerging markets
- Restraints
- Supply shortages
- Donor recruitment challenges
- Regulatory complexities
- High operational costs
- Opportunities
- Blood product innovations
- Expansion in emerging markets
- Advancements in storage and transportation
- Collaborations with pharmaceutical companies
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Blood Bank Market, By Product Type, 2021 - 2031 (USD Million)
- Whole Blood
- Red Blood Cell
- Platelet
- Plasma
- White Blood cell
- Global Blood Bank Market, By Function, 2021 - 2031 (USD Million)
- Collection
- Processing
- Testing
- Storage
- Transportation
- Global Blood Bank Market, By Bank Type, 2021 - 2031 (USD Million)
- Private
- Public
- Global Blood Bank Market, By End User, 2021 - 2031 (USD Million)
- Hospital
- Ambulatory Surgery Centers
- Pharmaceutical Companies
- Clinics & Nursing Homes
- Others
- Global Blood Bank Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Blood Bank Market, By Product Type, 2021 - 2031 (USD Million)
- Competitive Landscape
- Company Profiles
- American Association of Blood Banks
- Illinois Medical District
- Scottish National Blood
- America's Blood Centers
- Australian Red Cross Society
- Blood Bank of Alaska
- Canadian Blood Services
- Japanese Red Cross Society
- New York Blood Center
- Sanquin Blood Supply Foundation
- The American Red Cross
- Viitant
- Company Profiles
- Analyst Views
- Future Outlook of the Market